NUVISION BIOTHERAPIES LIMITED Financials
- Company number
- 09526225CopyCopy
- Registered office
- Medicity, D6 Building, Thane Road, Nottingham NG90 6BH
- Incorporated
- 07/04/2015
Company snapshot
- Status
- Active
- Employees
- 26 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
708.94%vs 20242024: £-177.05K
Total Assets
228.37%vs 20242024: £446.41K
Cash in Bank
2.00K%vs 20242024: £44.29K
Total Liabilities
-40.72%vs 20242024: £608.02K
Employees
+5vs 20242024: 21
In 2025, NUVISION BIOTHERAPIES LIMITED reported net assets of £1.08M. The same filing shows total assets of £1.47M, cash in bank of £928.80K and total liabilities of £360.45K. Reported headcount was 26 in 2025. Net Assets rose from £-177.05K in 2024 to £1.08M in 2025 (708.94%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
708.94%from £-177.05K in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures NUVISION BIOTHERAPIES LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+13.8%vs 2023+6.7% a year compound (CAGR)
Cash in Bank
+43.8%vs 2023+19.9% a year compound (CAGR)
Total Assets
+41.2%vs 2023+18.8% a year compound (CAGR)
Total Liabilities
+655%vs 2023+175% a year compound (CAGR)
Employees
+44.4%vs 2023+8Biggest increase
Total Liabilities+655%
£47.75K in 2023 to £360.45K in 2025
Every indicator Okredo holds for NUVISION BIOTHERAPIES LIMITED rose between 2023 and 2025. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, with net assets, cash in bank, total assets and employee numbers climbing alongside it. See the full year-by-year figures.
Ratios from the filed figures
Calculated from NUVISION BIOTHERAPIES LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 73.55%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 24.59%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 257.68%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 63.36%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for NUVISION BIOTHERAPIES LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 183.58K | 769.62K | 947.34K | -177.05K | 1.08M |
| Total Assets£ | 1.50M | 1.26M | 1.04M | 446.41K | 1.47M |
| Cash in Bank£ | 1.02M | 673.29K | 645.68K | 44.29K | 928.80K |
| Total Liabilities£ | 1.25M | 436.82K | 47.75K | 608.02K | 360.45K |
| Employees | 13 | 14 | 18 | 21 | 26 |
NUVISION BIOTHERAPIES LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for NUVISION BIOTHERAPIES LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
NUVISION BIOTHERAPIES LIMITED reported net assets of £1.08M for 2025. That compares with £-177.05K in 2024, a change of 708.94%.
NUVISION BIOTHERAPIES LIMITED reported total assets of £1.47M for 2025. That compares with £446.41K in 2024, a change of 228.37%.
NUVISION BIOTHERAPIES LIMITED reported cash in bank of £928.80K for 2025. That compares with £44.29K in 2024, a change of 2.00K%.
NUVISION BIOTHERAPIES LIMITED reported 26 employees in 2025, compared with 21 in 2024.
Between 2023 and 2025, NUVISION BIOTHERAPIES LIMITED's net assets rose by 13.8%, cash in bank rose by 43.8%, total assets rose by 41.2% and total liabilities rose by 655%. Net assets compounded at 6.7% a year across the two years to 2025, from £947.34K to £1.08M. Reported headcount went from 18 in 2023 to 26 in 2025 (+8).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.